273
Participants
Start Date
March 7, 2018
Primary Completion Date
November 13, 2020
Study Completion Date
December 10, 2025
Olaparib Continuous (28-Day cycle) 300 mg BD.
Two (2) 150 mg olaparib tablets should be taken at the same time each day, approximately 12 hours apart with one glass of water (approximately 250 mL).
Ceralasertib 160 mg OD + olaparib continuous 300 mg BD (28-day cycle).
Patients will be administered Ceralasertib OD at 160 mg from Day 1 to Day 7 (inclusive) of every 28-day cycle.
Adavosertib 150 mg BD + olaparib 200 mg BD (21-day cycle).
Patients will be administered adavosertib BD at 150mg from Day 1 to Day 3 and Day 8 to Day 10.
Research Site, Taoyuan District
Research Site, Changhua
Research Site, Brussels
Research Site, Brussels
Research Site, Dresden
Research Site, Ottignies
Research Site, Wilrijk
Research Site, Brasschaat
Research Site, Leuven
Research Site, Liège
Research Site, Namur
Research Site, Charleroi
Research Site, Cáceres
Research Site, Taipei
Research Site, Torino
Research Site, Taipei
Research Site, Mount Kisco
Research Site, Lake Success
Research Site, Taipei
Research Site, Taipei
Research Site, Mineola
Research Site, East Setauket
Research Site, Stony Brook
Research Site, Marseille
Research Site, Seongnam-si
Research Site, Caen
Research Site, Genova
Research Site, San Sebastián
Research Site, Rozzano
Research Site, Milan
Research Site, Milan
Research Site, Hamburg
Research Site, Towson
Research Site, Lecco
Research Site, Besançon
Research Site, Brescia
Research Site, Pavia
Research Site, Madrid
Research Site, Madrid
Research Site, Madrid
Research Site, Madrid
Research Site, Novara
Research Site, Cheongju-si
Research Site, Hanover
Research Site, Bordeaux
Research Site, Montpellier
Research Site, Rennes
Research Site, Birmingham
Research Site, Vigo
Research Site, Tours
Research Site, Knoxville
Research Site, Bologna
Research Site, Louisville
Research Site, Taichung
Research Site, Seville
Research Site, Seville
Research Site, Daegu
Research Site, Hazard
Research Site, Parma
Research Site, Cona
Research Site, Nantes
Research Site, Saint-Herblain
Research Site, Cincinnati
Research Site, Valencia
Research Site, Munster
Research Site, Meldola
Research Site, Angers
Research Site, Zaragoza
Research Site, Siena
Research Site, Milwaukee
Research Site, Pisa
Research Site, Witten
Research Site, Lille
Research Site, Ancona
Research Site, Frankfurt am Main
Research Site, Chicago
Research Site, Macerata
Research Site, Lyon
Research Site, Aurora
Research Site, Napoli
Research Site, München
Research Site, Kaohsiung Hsien
Research Site, Gilbert
Research Site, Villejuif
Research Site, Seattle
Research Site, Messina
Research Site, Anchorage
Research Site, New Haven
Research Site, Brick
Research Site, Calgary
Research Site, Kelowna
Research Site, Ottawa
Research Site, Toronto
Research Site, Brno
Research Site, Olomouc
Research Site, Prague
Research Site, Leipzig
Research Site, Cork
Research Site, Dublin
Research Site, Roma
Research Site, Breda
Research Site, Rotterdam
Research Site, The Hague
Research Site, Dąbrowa Górnicza
Research Site, Gdansk
Research Site, Gdynia
Research Site, Grzepnica
Research Site, Krakow
Research Site, Lodz
Research Site, Olsztyn
Research Site, Poznan
Research Site, Warsaw
Research Site, Wroclaw
Research Site, Lisbon
Research Site, Lisbon
Research Site, Loures
Research Site, Porto
Research Site, Vila Nova de Gaia
Research Site, Goyang-si
Research Site, Incheon
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Barcelona
Research Site, Barcelona
Research Site, Palma de Mallorca
Research Site, Sant Cugat del Vallès
Research Site, Aberdeen
Research Site, Bristol
Research Site, Cardiff
Research Site, Durham
Research Site, Edinburgh
Research Site, Leicester
Research Site, London
Research Site, London
Research Site, London
Research Site, Manchester
Research Site, Nottingham
Research Site, Southampton
Lead Sponsor
AstraZeneca
INDUSTRY